Brain Health · Women's Hormones

Picture two women born in Sweden in 1944. They grew up in the same decade and turned 70 within months of each other. On paper, their brains should have aged at about the same pace.

Now picture their brain scans. One shows many tiny trouble spots in small blood vessels. The other looks much cleaner—same birth year, same country, different brain plumbing.

Researchers who studied women like these think the gap may come down to a simple question: how many years did each woman have estrogen on board?

Alzheimer's disease and hormones

Ask most people what estrogen does, and they usually stop at reproduction. Ask what happens when it fades, and many people think only of hot flashes. That is like describing a smartphone as a call device. It is true, but it leaves out a lot.

The brain changes with hormones. That may help explain why women are more likely than men to develop Alzheimer's disease. Women also experience major shifts in estrogen at key points in life. This study adds to research on estrogen and brain health.

New research on Alzheimer's disease and hormones points to the brain's blood vessels. In a study of 352 Swedish women, those with longer lifetime estrogen exposure, especially women who reached menopause later, had fewer MRI signs of small vessel damage at age 70. The study shows an association, not proof that estrogen protects the brain.

What the researchers found

The team studied 352 healthy women from the Gothenburg H70 Birth Cohort Studies, all born in 1944. Each woman had an MRI scan at age 70, and most had another at 75.

They also reported their reproductive span, which ran from their first period to menopause, or to surgical removal of both ovaries. They said whether they had used birth control pills or menopausal hormone therapy, sometimes called female hormone therapy. These details served as stand-ins for lifetime estrogen exposure. The researchers did not measure hormone levels directly.

The scans looked for signs of small vessel disease. These included white-matter spots, tiny fluid-filled cavities called lacunes, small bleeds called microbleeds, and large fluid spaces around deep brain vessels. In a way, the vessels are the brain's plumbing, and these are the drips and weak spots an inspector would notice.

What stood out

For each extra year of reproductive span, the odds of having two or more signs of small vessel disease at age 70 dropped by about 8 percent.

The pattern was driven more by later menopause than by an earlier first period. In other words, the end of the timeline seemed to matter more than the start.

Women who had used menopausal hormone therapy also tended to have fewer signs of small vessel disease. Their white matter also looked better organized.

The study found one more wrinkle. Among women with the APOE-ε4 gene variant, which raises Alzheimer's risk, hormone therapy was tied to greater cortical thickness in brain areas that are more vulnerable to the disease. Among women without that variant, there was no clear link.

Anna Marseglia, a brain expert at Sweden's Karolinska Institutet, said the findings suggest hormonal exposure across a woman's life may have lasting effects on brain blood vessel health. She also pointed to the vessels themselves as a likely link between estrogen and brain aging.

What the study does not prove

It helps to be careful here. This was an association study, not proof of cause and effect. It did not test estrogen directly. Other changes at menopause may also matter.

That is why the study's first author, Yale brain scientist Giulia Lorenzon, said the results do not justify recommending hormone therapy for prevention.

The research does raise a sharper question. Women still lack sex-specific ways to prevent cognitive decline, so understanding Alzheimer's disease and hormones remains important. It also gives researchers a clear place to look: not only at neurons, but at the blood vessels that feed them.

That matters. For years, menopause was seen mainly as the end of fertility. This study suggests it may also be a key moment for the brain's blood vessels, and that the timing of estrogen loss could echo for decades.

Which brings us back to the two women in Sweden. No single hormone will explain every difference between their scans. But the next time someone says estrogen is only a reproductive hormone, remember that the brain may have been keeping score all along.

Frequently Asked Questions About Alzheimer's Disease and Hormones

These findings come from a study of 352 Swedish women born in 1944 and do not show cause and effect. Researchers did not measure hormone levels directly; they used reproductive span and hormone use as stand-ins. Some links did not hold under stricter tests, and the results may not apply to larger groups.

A major review found no strong evidence that menopausal hormone therapy changes dementia risk, for better or worse. The study's first author said the results cannot be used to recommend hormone therapy for prevention.